EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C12H14ClNO |
| Net Charge | 0 |
| Average Mass | 223.703 |
| Monoisotopic Mass | 223.07639 |
| SMILES | N[C@]1(c2ccccc2Cl)CCCCC1=O |
| InChI | InChI=1S/C12H14ClNO/c13-10-6-2-1-5-9(10)12(14)8-4-3-7-11(12)15/h1-2,5-6H,3-4,7-8,14H2/t12-/m0/s1 |
| InChIKey | BEQZHFIKTBVCAU-LBPRGKRZSA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antinociceptive agent Any agent that inhibits nociception. human xenobiotic metabolite Any human metabolite produced by metabolism of a xenobiotic compound in humans. NMDA receptor antagonist Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs. nicotinic antagonist An antagonist at the nicotinic cholinergic receptor. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | antinociceptive agent Any agent that inhibits nociception. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. nicotinic antagonist An antagonist at the nicotinic cholinergic receptor. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (S)-norketamine (CHEBI:234434) is a norketamine (CHEBI:91519) |
| (S)-norketamine (CHEBI:234434) is enantiomer of (R)-norketamine (CHEBI:234433) |
| Incoming Relation(s) |
| (R)-norketamine (CHEBI:234433) is enantiomer of (S)-norketamine (CHEBI:234434) |
| IUPAC Name |
|---|
| (2S)-2-amino-2-(2-chlorophenyl)cyclohexanone |
| Synonyms | Source |
|---|---|
| (2S)-2-amino-2-(2-chlorophenyl)cyclohexan-1-one | IUPAC |
| N-demethyl-(S)-(−)-ketamine | ChEBI |
| (S)-2-amino-2-(2-chlorophenyl)cyclohexanone | ChEBI |
| S-norketamine | ChEBI |
| (−)-norketamine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| HK1079461 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:83777-65-5 | ChEBI |
| Citations |
|---|